Spanish National Health Systemfaricimabranibizumabbrolucizumabafliberceptneovascular age-related macular degeneration (nAMD)
…s conducted from the payer perspective using cost data from the Spanish National Health System.Methods A model-based analysis compared five anti-VEGF agents—i…